ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being named chief operations officer—now adds Reference Business Unit president to his title.
September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new Advanced Practice Clinical Laboratory Training Center opened its doors this week and took a bold step toward solving a nationwide shortage of clinical laboratory scientists. This state-of-the-art facility is more than a training site; it’s a model […]
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests.
The partnership combines Tasso’s clinical grade blood collection solutions, such as the Tasso+ device pictured above, with ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
Nicola Longo, MD, PhD, has spent more than 20 years at University of Utah Health and ARUP Laboratories treating patients in his clinic and working with wife Marzia Pasquali, PhD, FACMG, to advance the diagnosis of inherited metabolic disorders.
Dan Albertson, MD, will serve as president of the University Business Unit.
ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder